$KLTR

Azaria Eynav sold $18K of KLTR

Azaria Eynav (See Remarks) sold 12,073 shares of KALTURA INC (KLTR) at $1.48 on 2026-06-16 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Azaria Eynav
Published Jun 17, 2026, 2:24 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 17, 2026, 2:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$KLTR
Neutral
high confidence
Mentioned
$KLTR
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KLTRNeutralLow
01

Why it matters

The disclosure adds incremental information about insider liquidity/positioning but is not, by itself, a fundamental change (no earnings, guidance, deal, or regulatory action).

02

Market read

Traders may monitor for follow-on insider activity, but the 10b5-1 framing generally limits interpretive weight.

03

What to watch

The filing does not indicate whether other insiders are buying, nor does it provide performance context; the market may treat it as routine unless paired with additional negative disclosures.

Relevance 2/10Novelty 6/10Timing: Filed 2026-06-17; transaction dated 2026-06-16

Background

This is an SEC Form 4 insider transaction for Kaltura, reported by officer Azaria Eynav, executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$KLTRNeutralHigh confidence
Context

Kaltura (KLTR) disclosed an officer’s open-market sale of 12,073 shares at $1.4842 on 2026-06-16 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained move; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction with a pre-arranged 10b5-1 plan, and the disclosed sale size is modest relative to typical liquidity for public small/mid-caps.

Market effects

Minimal—this is company-specific insider activity with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with internal caution; traders may still fade rallies if selling cadence continues.

Key entities

  • Kaltura

    Subject of the Form 4 insider sale disclosure (KLTR).

  • Azaria Eynav

    Officer who sold 12,073 shares in an open-market transaction under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$KLTRMed

Kaltura Wins Best Event AI Technology at Eventex 2026 For the Fourth Straight Year

Kaltura (Nasdaq: KLTR) said it won “Best Event AI Technology” at the Eventex Awards for the fourth straight year. The company attributed the win to its Agentic Avatar event assistants, including real-time conversational features and analytics. Kaltura reported powering 9,000+ events for 1.3 million attendees, with 69% registration-to-attendance and 51% post-event participation.

$ASPEMedAI 8/10

ARCH Venture Fund X, L.P. (CRANDELL KEITH, Burow Kristina) purchased $18.0M of ASPE (indirect holdings)

ARCH Venture Fund X, L.P. purchased 1,200,000 indirectly-held shares of Aspen Neuroscience, Inc. (ASPE) at $15.00 ($18.00M total) on 2026-11-02. Filed jointly with ARCH Venture Fund X Overage, L.P. (10% owner), ARCH Venture Partners X, L.P. (10% owner), ARCH Venture Partners X Overage, L.P. (10% owner), ARCH Venture Partners X, LLC (10% owner), CRANDELL KEITH (10% owner), Burow Kristina (10% owner), GILLIS STEVEN (10% owner) and NELSEN ROBERT (10% owner).

$ASPELow

ARCH Venture Fund X, L.P. (CRANDELL KEITH, Burow Kristina) purchased $2.0M of ASPE

ARCH Venture Fund X, L.P. purchased 133,333 shares of Aspen Neuroscience, Inc. (ASPE) at $15.00 ($2.00M total) across 2 trades on 2026-11-02. Filed jointly with ARCH Venture Fund X Overage, L.P. (10% owner), ARCH Venture Partners X, L.P. (10% owner), ARCH Venture Partners X Overage, L.P. (10% owner), ARCH Venture Partners X, LLC (10% owner), CRANDELL KEITH (10% owner), Burow Kristina (10% owner), GILLIS STEVEN (10% owner) and NELSEN ROBERT (10% owner).